đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
ACTT-4 will evaluate the combination of baricitinib and remdesivir compared...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2020-12-02
Trial ID
NCT04640168
Treatments Being Tested
The aim of the study is to compare how different formulations of AZD0530 ar...
Status
Completed
Location
Research Site
Start Date
2008-11
Trial ID
NCT00771979
Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled,...
Status
Completed
Location
Shoals Medical Trials
Start Date
2020-06-24
Trial ID
NCT04233424
Treatments Being Tested
The aim of the study was to compare the profiles of 25-hydroxyvitamin D ser...
Status
Completed
Location
GdaĆski Uniwersytet Medyczny
Start Date
2023-02-17
Trial ID
NCT06010121
Treatments Being Tested
This study is a multicenter, open-label study of polatuzumab vedotin admini...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-10-15
Trial ID
NCT02257567
This is a randomised double-blind placebo-controlled trial of L-serine in H...
Status
Unknown
Location
University College London
Start Date
2023-08-21
Trial ID
NCT06113055
This study intends to demonstrate bioequivalence of two formulations, the e...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-07
Trial ID
NCT00449774
Treatments Being Tested
The objective of the present study was to evaluate the effect of the consum...
Status
Completed
Location
Centro de Investigacion En Alimentacion Y Desarrollo, A.C.
Start Date
2018-12-01
Trial ID
NCT04335708
Treatments Being Tested
This study is divided in 2 parts. Part 1a is being conducted to evaluate th...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-04
Trial ID
NCT02853435
Treatments Being Tested
The objective of this study is to demonstrate bioequivalence of 4 mg tablet...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-01
Trial ID
NCT00786240
Treatments Being Tested